5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

scientific article published on June 1984

5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0014-2999(84)90333-9
P698PubMed publication ID6479216

P2093author name stringShannon M
Glennon RA
Battaglia G
Titeler M
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)23-29
P577publication date1984-06-01
P1433published inEuropean Journal of PharmacologyQ1376712
P1476title5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).
P478volume102

Reverse relations

cites work (P2860)
Q341671041-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats
Q358882715-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs
Q487282335-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex.
Q341856975-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats
Q35851456A review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat
Q42563347Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors
Q34192427Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression
Q35942133Centrally active 5-HT receptor agonists and antagonists
Q48362746Characteristics of agonist displacement of [3H]ketanserin binding to platelet 5-HT2A receptors: implications for psychiatric research
Q48787534Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats
Q43633225Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness
Q35803439Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.
Q33899072Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action
Q52165520Effects of serotonin 5-HT(1) and 5-HT(2) receptor agonists in a conditioned taste aversion paradigm in the rat.
Q44574538Effects of serotonin 5-HT(1/2) receptor agonists in a limited-access operant food intake paradigm in the rat.
Q73314507Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats
Q42707728Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation
Q59478852First Intramolecular Alkylation of Nitriles with Primary and Secondary Alcohols Catalyzed by Iridium Complexes
Q41265940Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat.
Q34041519Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis
Q24595389Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model
Q43503640Hyper-responsiveness to 5-HT2Agonists by Tumour-linked Arterioles in Mice: Consequences for Tumour Growth
Q48488302Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain
Q40457646Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?
Q41387206Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists
Q34427738Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist
Q39093171Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens
Q74097654Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment
Q34167036Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens
Q27027381Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Q48787465Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype
Q37602790Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice
Q33178556Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI).
Q52054019Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists
Q48636711Serotonin 5-HT1A and 5-HT2/1C receptors in the midbrain periaqueductal gray differentially modulate defensive rage behavior elicited from the medial hypothalamus of the cat.
Q38004450Serotonin receptor subtypes and sexual behavior
Q47899794Serotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurones in vitro
Q43570514Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors
Q28289039Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors
Q48389932The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats
Q51112892Use of the harmonic mean to the determination of dissociation constants of stereoisomeric mixtures of biologically active compounds.
Q52252661Variability in the effects of 4-bromo-2,5-dimethoxyamphetamine (DOB) on operant behavior of squirrel monkeys

Search more.